Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Income towards Parent Company: 2009-2011

Historic Income towards Parent Company for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$116.2 million.

  • Lexicon Pharmaceuticals' Income towards Parent Company fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$115.1 million, marking a year-over-year decrease of 16.06%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.19% down from last year.
  • As of FY2011, Lexicon Pharmaceuticals' Income towards Parent Company stood at -$116.2 million, which was down 14.19% from -$101.8 million recorded in FY2010.
  • Over the past 5 years, Lexicon Pharmaceuticals' Income towards Parent Company peaked at -$93.3 million during FY2009, and registered a low of -$116.2 million during FY2011.
  • For the 3-year period, Lexicon Pharmaceuticals' Income towards Parent Company averaged around -$103.8 million, with its median value being -$101.8 million (2010).
  • Data for Lexicon Pharmaceuticals' Income towards Parent Company shows a maximum YoY declined of 14.19% (in 2011) over the last 5 years.
  • Over the past 3 years, Lexicon Pharmaceuticals' Income towards Parent Company (Yearly) stood at -$93.3 million in 2009, then declined by 9.06% to -$101.8 million in 2010, then decreased by 14.19% to -$116.2 million in 2011.